Lu S.Wang Q.Zhang G.Dong X.Yang C.-T.Song Y.Chang G.-C.Lu Y.Pan H.Chiu C.-H.Wang Z.Feng J.Zhou J.Xu X.Guo R.Chen J.Yang H.Chen Y.Yu Z.Shiah H.-S.Wang C.-C.Yang N.Fang J.Wang P.Wang K.Hu Y.He J.Wang Z.Shi J.Chen S.Wu Q.Sun C.Li C.Wei H.Cheng Y.Su W.-C.Hsia T.-C.Cui J.Sun Y.Ou S.-H.I.Zhu V.W.CHIH-HSIN YANG2022-08-102022-08-1020221556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120306113&doi=10.1016%2fj.jtho.2021.10.024&partnerID=40&md5=8a4258346f70774891f72103058c7a74https://scholars.lib.ntu.edu.tw/handle/123456789/616493[SDGs]SDG3Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trialconference paper10.1016/j.jtho.2021.10.024348017492-s2.0-85120306113